Analysis of prenatal diagnosis results of 206 thalassemia families

( views:332, downloads:0 )
Author:
LI Li-yan(Prenatal Diagnosis and Genetic Disease Diagnosis Center, Southern Medical University Nanfang Hospital, Guangzhou 510515, China)
ZHONG Mei(Prenatal Diagnosis and Genetic Disease Diagnosis Center, Southern Medical University Nanfang Hospital, Guangzhou 510515, China)
CHEN Cui-hua(Prenatal Diagnosis and Genetic Disease Diagnosis Center, Southern Medical University Nanfang Hospital, Guangzhou 510515, China)
SONG Lan-lin(Prenatal Diagnosis and Genetic Disease Diagnosis Center, Southern Medical University Nanfang Hospital, Guangzhou 510515, China)
JIN Wang-jie(Prenatal Diagnosis and Genetic Disease Diagnosis Center, Southern Medical University Nanfang Hospital, Guangzhou 510515, China)
WANG Zhi-jian(Prenatal Diagnosis and Genetic Disease Diagnosis Center, Southern Medical University Nanfang Hospital, Guangzhou 510515, China)
Journal Title:
Chinese Journal of Perinatal Medicine
Issue:
Volume 15, Issue 01, 2012
DOI:
10.3760/cma.j.issn.1007-9408.2012.01.003
Key Word:
Thalassemia;Prenatal diagnosis;Sequence analysis,DNA

Abstract: Objective To summarize the geographical distribution,phenotype and genotype data of 206 thalassemia families underwent prenatal diagnosis to provide information for clinical genetic counseling and avoid the birth of severe thalassemia children. Methods Totally,206 thalassemia families were collected from Southern Medical University Nanfang Hospital from January 2008 to December 2009.Genomic DNA was extracted from peripheral blood,villus,amniotic fluid or cord blood from the couples or the fetuses.Gap-polymerase chain reaction (gap-PCR) and reverse dot blot (RDB) technology were used to detect the common α and β-thalassemia mutations.DNA sequencing was used to detect the rare mutations.Follow-up visit were done half a year after the fetuses were born. Results The 206 thalassemia families came from 12 provinces and areas across China,including Heilongjiang province.Mutations detected in α-thalassemia families included --SEA/,-α3.7/,-α4.2/,αCS α/ and αQS α/,which were all included in the testing kit. While there were 4 kinds of β-thalassemia mutations,Gγ+ (A γδβ)0,-28(A→C),CD54-58(-TATGGGCAACCCT) and CD37(G→A),could not be identified with routine testing kit. The 57 α-thalassemia families consisted of 11(19.3%) severe thalassemia,induding 8 Bart's hydrops syndrome and 3 Hb H disease,26(45.6%) heterozygote and 20(35.1%) normal infants,and the 149 β-thalassemia majors families consisted of 28 (18.8%) severe thalassemia,82(55.0%) heterozygote and 39 (26.2%) normal infants.Among the β-thalassemia heterozygotes,there was one 13-trisomy.Follow-up visit found that babies with Bart ' s hydrops syndrome (n =8),Hb H disease (n =3),β-thalassemia majors (n =28) and β thalassemia heterozygote combined with 13-trisomy(n=1) were aborted. Conclusions Thalassemia was found in some north area other than south of China,which should be paid more attention by clinicians.Gap-PCR and PCR-RDB technology are effective measures for thalassemia prenatal diagnosis in identifying major thalassemia fetuses before their birth,thus reduce the birth rate of thalassemia baby.But missed diagnosis might exist during the screening,so it is necessary to perform DNA sequencing on those patients with positive symptoms and negative common genetic diagnostic results.At the same time,prenatal diagnosis of chromosomal disorders should not be neglected for high-risk families.

  • [1]全国血红蛋白病研究协作组.20省、市、自治区60万人血红蛋白病调查.中华医学杂志,1983,63:382-385.
  • [2]Ko TM,Xu X. Molecular study and prenatal diagnosis of alpha-and beta-thalassemias in Chinese. J Formos Med Assoc,1998,97:5-15.
  • [3]Xu XM,Zhou YQ,Luo GX,et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province:implications for the future health burden and population screening.J Clin Pathol,2004,57:517-522.
  • [4]Ko TM,Tseng LH,Hsieh FJ,et al. Rapid detection of Chinese Gγ+ (Aγδβ)0-thalassemia by polymerase chain reaction.Acta Haematol,1993,89:80-81.
  • [5]李文军,老雄武,贾世奇,等.一个少见的β地中海贫血突变家系.中华医学遗传学杂志,2003,20:468-470.
  • [6]NiehuisAW,Benz EJ. The thalassemias//Cecil RLF,Bennett JC,Plum F.Cecil textbook of medicine. 20th ed.London:W.B.Sauders Company,1996:877.
  • [7]Peres MJ,Carreiro MH,Machado MC,et al. Neonatal screening of hemoglobinopathies in a population residing in Portugal.Acta Med Port,1996,9:135-139.
  • [8]Modell B,Harris R,Lane B,et al.Informed choice in genetic screening for thalassaemia during pregnancy:audit from a national confidential inquiry.BMJ,2000,320:337-341.
  • [9]余伍忠,李厚钧,张宇红,等.中国西北三省区β地中海贫血基因突变类型及其分布特点.中华医学遗传学杂志,1998,15:224-228.
  • [10]鲍扬漪.东北、华北地区地中海贫血12例临床分析.安徽医学,1994,15:50-51.
  • [11]雷平冲,张茵,伍学强,等.河南省β地中海贫血基因突变类型的检验研究.河南医学研究,2002,11:5-6.
  • [12]蒋南华,梁徐,梁荣等.广西地区β地中海贫血突变基因的分析.广西医科大学学报,1994,11:125-127.
  • [13]徐湘民.见于中国人的HPFH和δβ-地中海贫血的分子基础.中华医学遗传学杂志,1998,15:315-317.
  • [14]Li DZ,Liao C,Li J.A novel β-thalassemic allde due to a thirteen nucleotide deletion:codons 54-58 (-TATGGGCAACCCT). Ann Hematol,2009,88:799-801.
  • [15]Li Q,Li LY,Huang SW,et al.Rapid genotyping of known mutations and polymorphisms in beta-globin gene based on the DHPLC profile patterns of homoduplexes and heteroduplexes.Clin Biochem,2008,41:681-687.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn